Human VEGF R1/Flt-1 Quantikine SixPak (6 Plates)

• Supplier: R&D Systems
• Catalog: SVR100B
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (100 µL), Serum (100 µL), EDTA Plasma (100 µL), Saliva (100 µL), Follicular Fluid (100 µL)
• Sensitivity: 13.3 pg/mL
• Range: 31.2 - 2,000 pg/mL (Serum, Saliva, Cell Culture Supernates, EDTA Plasma, Follicular Fluid)
• Format: 96-well strip plate
• Description: The Quantikine Human VEGF R1 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human soluble VEGF R1 in cell culture supernates, serum, plasma, saliva, and follicular fluid
• Gene: FLT1

Product References

Analysis of plasma cytokines and angiogenic factors in patients with pretreated - Analysis of plasma cytokines and angiogenic factors in patients with pretreated

Necchi A, Pennati M, Zaffaroni N, Landoni E, Giannatempo P, Raggi D, Schwartz LH, Morosi C, Crippa F, Fare E, Nicolai N, Lanocita R, Sava T, Sacco C, Messina C, Ortega C, De Braud FG, Salvioni R, Daidone MG, Gianni AM, Mariani L. Br J Cancer. 2014 Jan 7;110(1):26-33.

Integrating multiple 'omics' analyses identifies serological protein biomarkers - Integrating multiple 'omics' analyses identifies serological protein biomarkers

Liu LY, Yang T, Ji J, Wen Q, Morgan AA, Jin B, Chen G, Lyell DJ, Stevenson DK, Ling XB, Butte AJ. BMC Med. 2013 Nov 6;11:236.

Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. - Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.

Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z. Nature. 2012 May 9;485(7398):333-8.

Expression and prognostic value of circulating angiogenic cytokines in pancreatic - Expression and prognostic value of circulating angiogenic cytokines in pancreatic

Rahbari NN, Schmidt T, Falk CS, Hinz U, Herber M, Bork U, Buchler MW, Weitz J, Koch M. BMC Cancer. 2011 Jul 5;11:286.

Phase I and pharmacokinetic study of sunitinib in pediatric patients with - Phase I and pharmacokinetic study of sunitinib in pediatric patients with

Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade-Bender J, Ivy P, Grier HE, Adamson PC, Blaney SM. Clin Cancer Res. 2011 Aug 1;17(15):5113-22.

Prognostic significance of angiogenic factors in uterine cervical cancer. - Prognostic significance of angiogenic factors in uterine cervical cancer.

Landt S, Wehling M, Heidecke H, Jeschke S, Korlach S, Stoblen F, Schmid P, Blohmer JU, Lichtenegger W, Sehouli J, Kummel S. Anticancer Res. 2011 Aug;31(8):2589-95.

In vitro vascular tube formation testing as a tool for treatment - In vitro vascular tube formation testing as a tool for treatment

Landt S, Heidecke H, Korlach S, Reuter C, Schwidde I, Barinoff J, Thill M, Sehouli J, Kummel S. Anticancer Res. 2011 Aug;31(8):2609-15.

Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates - Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates

Kosugi T, Nakayama T, Li Q, Chiodo VA, Zhang L, Campbell-Thompson M, Grant M, Croker BP, Nakagawa T. Am J Physiol Renal Physiol. 2010 Mar;298(3):F609-16. doi:

Signs of reduced angiogenic activity after surgical removal of deeply - Signs of reduced angiogenic activity after surgical removal of deeply

Bourlev V, Iljasova N, Adamyan L, Larsson A, Olovsson M. Fertil Steril. 2010 Jun;94(1):52-7.

An automated method for the determination of the sFlt-1/PIGF ratio in the - An automated method for the determination of the sFlt-1/PIGF ratio in the

Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H. Am J Obstet Gynecol. 2010 Feb;202(2):161.e1-161.e11. doi: